Have the Testosterone Trials Demonstrated the Effectiveness of Testosterone Therapy in Older Men without Classical Hypogonadism?

Snyder PJ , Bhasin S , Cunningham GR . Effects of testosterone treatment in older men. N Engl J Med 2016; 374: 611–24. https://dx-doi-org.web.bisu.edu.cn/10.1056/NEJMoa1506119

Wu FCW , Tajar A , Pye SR . Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab 2008; 93: 2737–45. https://dx-doi-org.web.bisu.edu.cn/10.1210/jc.2007-1972

Basaria S , Coviello AD , Travison TG . Adverse events associated with testosterone administration. N Engl J Med 2010; 363: 109–22. https://dx-doi-org.web.bisu.edu.cn/10.1056/NEJMoa1000485

Wu FCW , Tajar A , Beynon JM . Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 2010; 363: 123–35. https://dx-doi-org.web.bisu.edu.cn/10.1056/NEJMoa0911101

Tajar A , Huhtaniemi IT , O'Neill TW . Characteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS). J Clin Endocrinol Metab 2012; 97: 1508–16. https://dx-doi-org.web.bisu.edu.cn/10.1210/jc.2011-2513

Kapoor D , Goodwin E , Channer KS . Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol 2006; 154: 899–906.

Madersbacher S , Grunberger T , Maier U . Andrological status before and after liver transplantation. J Urol 1994; 15: 1251–4.

Chan YX , Knuiman MW , Hung J . Neutral associations of testosterone, dihydrotestosterone and estradiol with fatal and non-fatal cardiovascular events and mortality in men aged 17-97 years. Clin Endocrinol 2016. E-pub 23 April. https://dx-doi-org.web.bisu.edu.cn/10.1111/cen.13089

Finkle WD , Greenland S , Ridgeway GK . Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men. PLoS One 2014; 9(1): e85805. https://dx-doi-org.web.bisu.edu.cn/10.1371/journal.pone.0085805

Anderson JL , May HT , Lappé DL . Impact of testosterone replacement therapy on myocardial infarction, stroke, and death in men with low testosterone concentrations in an integrated health care system. Am J Cardiol 2015; 117: 794–9. https://dx-doi-org.web.bisu.edu.cn/10.1016/j.amjcard.2015.11.063

Wallis CJ , Lo K , Lee Y . Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study. Lancet Diabetes Endocrinol 2016; 4: 498–506.

Xu L , Freeman G , Cowling BJ . Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials. BMC Med 2013; 11:108. https://dx-doi-org.web.bisu.edu.cn/10.1186/1741-7015-11-108

Yeap BB , Alfonso H , Chubb SA . In older men an optimal plasma testosterone is associated with reduced all-cause mortality and higher dihydrotestosterone with reduced ischemic heart disease mortality, while estradiol levels do not predict mortality. J Clin Endocrinol Metab 2014; 99: E9–18. https://dx-doi-org.web.bisu.edu.cn/10.1210/jc.2013-3272

Hamilton EJ , Davis WA , Makepeace A . Prevalence and prognosis of a low serum testosterone in men with type 2 diabetes: The Fremantle Diabetes Study Phase. Clin Endocrinol 2016. E-pub 23 April. https://dx-doi-org.web.bisu.edu.cn/10.1111/cen.13087

FDA. Bone, Reproductive and Urologic Drugs Advisory Committee -Slides for the June 4, 2015: Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting. http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm452156.htm

Bakhshi V , Elliott M , Gentili A . Testosterone improves rehabilitation outcomes in ill older men. J Am Geriatr Soc 2008; 48: 550–3.

Hackett G , Cole N , Bhartia M . Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes. J Sex Med 2013; 10: 1612–27. https://dx-doi-org.web.bisu.edu.cn/10.1111/jsm.12146

Yassin DJ , Doros G , Hammerer PG . Long term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life. J Sex Med 2014; 11: 1567–76. https://dx-doi-org.web.bisu.edu.cn/10.1111/jsm.12523